Abstract
Increasing use of ultrasonography during pregnancy has uncovered a range of parenchymal lesions within the lung, some of which will, if left, be a cause of morbidity and occasional mortality. These include congenital cystic adenomatoid malformations (CCAM), bronchopulmonary sequestration (BPS), congenital lobar & segmental emphysema and bronchogenic cysts. Adverse antenatal features include mediastinal shift, caval obstruction, and (rarely) hydrops. This review aims to define current thoughts on these lesions and suggest appropriate management.
Keywords: Cystic adenomatoid malformation, bronchopulmonary sequestration, fetal hydrops, lobectomy, Congenital Parenchymal Lesions, segmental emphysema, bronchogenic cysts, embryological origins, mechanical compression, malignancy
Current Respiratory Medicine Reviews
Title: Congenital Parenchymal Lesions of the Lung
Volume: 7 Issue: 2
Author(s): Nada Sudhakaran and Mark Davenport
Affiliation:
Keywords: Cystic adenomatoid malformation, bronchopulmonary sequestration, fetal hydrops, lobectomy, Congenital Parenchymal Lesions, segmental emphysema, bronchogenic cysts, embryological origins, mechanical compression, malignancy
Abstract: Increasing use of ultrasonography during pregnancy has uncovered a range of parenchymal lesions within the lung, some of which will, if left, be a cause of morbidity and occasional mortality. These include congenital cystic adenomatoid malformations (CCAM), bronchopulmonary sequestration (BPS), congenital lobar & segmental emphysema and bronchogenic cysts. Adverse antenatal features include mediastinal shift, caval obstruction, and (rarely) hydrops. This review aims to define current thoughts on these lesions and suggest appropriate management.
Export Options
About this article
Cite this article as:
Sudhakaran Nada and Davenport Mark, Congenital Parenchymal Lesions of the Lung, Current Respiratory Medicine Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339811794927815
DOI https://dx.doi.org/10.2174/157339811794927815 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology Development of New Fibrinolytic Agents
Current Pharmaceutical Design Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Editorial (Thematic Issues: Autoimmunity and Autoinflammation: Cardiovascular Drug Targets and Design)
Current Pharmaceutical Design Effect of Non-antihypertensive Drugs on Endothelial Function in Hypertensive Subjects Evaluated by Flow-mediated Vasodilation
Current Vascular Pharmacology Serendipity of Erythromycin in the Management of Periprosthetic Inflammation
Current Drug Therapy Pathophysiology of Platelet Resistance to Anti-Aggregating Agents in Insulin Resistance and Type 2 Diabetes: Implications for Anti-Aggregating Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews Neuroprotective Effects of Quercetin: From Chemistry to Medicine
CNS & Neurological Disorders - Drug Targets Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?
Current Medicinal Chemistry Cardiovascular Complications of HIV Infection and Treatment
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Oxidative Stress in Methamphetamine and MDMA-induced Toxicity
Mini-Reviews in Organic Chemistry Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Current Hypertension Reviews Metabolic Functions of Myostatin and GDF11
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Use of Medications for the Treatment of Alcohol Dependence: A Retrospective Study Conducted in 2011-2012
Current Drug Research Reviews Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Contrast Echocardiography: An Update on Clinical Applications
Current Pharmaceutical Design